Pregled bibliografske jedinice broj: 297345
Synthesis and Antiproliferative Evaluation of Novel Bis-Styrylbenzothiazol-3-ium Salts
Synthesis and Antiproliferative Evaluation of Novel Bis-Styrylbenzothiazol-3-ium Salts // Monatshefte fuer Chemie, 139 (2008), 5; 569-573 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 297345 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Synthesis and Antiproliferative Evaluation of Novel Bis-Styrylbenzothiazol-3-ium Salts
Autori
Ćaleta, Irena ; Kralj, Marijeta ; Marjanović, Marko ; Karminski-Zamola, Grace
Izvornik
Monatshefte fuer Chemie (0026-9247) 139
(2008), 5;
569-573
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Synthesis and antiproliferative evaluation; Novel Bis-Styrylbenzothiazol-3-ium Salts
Sažetak
A series of bis-styrylbenzothiazol-3-ium salts containing different substituents 4-12 were synthesized from 2-methylbenzothiazole by condensation of quaternary salts 1-3 with p-substituted benzaldehydes. All compounds were characterized by IR, 1H and 13C NMR, MS and elemental analysis. Synthesized compounds 4-12 were screened for antitumor activities. Based on presented in vitro screening results we may conclude that compounds 4-6 and 9 showed the best cell growth inhibitory activity.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)
125-0982464-1356 - Novi heterocikli kao antitumorski i antivirusni (pametni) lijekovi (Hranjec, Marijana, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Marko Marjanović
(autor)
Grace Karminski-Zamola
(autor)
Marijeta Kralj
(autor)
Irena Ćaleta
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI